Borden EC - Search Results

1

Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse.

Gibson DF, Johnson DA, Goldstein D, Langan-Fahey SM, Borden EC, Jordan VC. Gibson DF, et al. Among authors: borden ec. Breast Cancer Res Treat. 1993;25(2):141-50. doi: 10.1007/BF00662139. Breast Cancer Res Treat. 1993. PMID: 8347846

2

Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2.

Robinson SP, Goldstein D, Witt PL, Borden EC, Jordan VC. Robinson SP, et al. Among authors: borden ec. Breast Cancer Res Treat. 1990 Feb;15(2):95-101. doi: 10.1007/BF01810781. Breast Cancer Res Treat. 1990. PMID: 2138919

3

Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen.

Goldstein D, Bushmeyer SM, Witt PL, Jordan VC, Borden EC. Goldstein D, et al. Among authors: borden ec. Cancer Res. 1989 May 15;49(10):2698-702. Cancer Res. 1989. PMID: 2469536

4

Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro.

Gottardis MM, Wagner RJ, Borden EC, Jordan VC. Gottardis MM, et al. Among authors: borden ec. Cancer Res. 1989 Sep 1;49(17):4765-9. Cancer Res. 1989. PMID: 2758410

5

Effects of interferon beta ser and transforming growth factor beta on prostatic cell lines.

Goldstein D, O'Leary M, Mitchen J, Borden EC, Wilding G. Goldstein D, et al. Among authors: borden ec. J Urol. 1991 Oct;146(4):1173-7. doi: 10.1016/s0022-5347(17)38034-5. J Urol. 1991. PMID: 1895445

6

Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.

Goldstein D, Sielaff KM, Storer BE, Brown RR, Datta SP, Witt PL, Teitelbaum AP, Smalley RV, Borden EC. Goldstein D, et al. Among authors: borden ec. J Natl Cancer Inst. 1989 Jul 19;81(14):1061-8. doi: 10.1093/jnci/81.14.1061. J Natl Cancer Inst. 1989. PMID: 2472488 Clinical Trial.

7

Effects of cytokines on the pituitary-adrenal axis in cancer patients.

Nolten WE, Goldstein D, Lindstrom M, McKenna MV, Carlson IH, Trump DL, Schiller J, Borden EC, Ehrlich EN. Nolten WE, et al. Among authors: borden ec. J Interferon Res. 1993 Oct;13(5):349-57. doi: 10.1089/jir.1993.13.349. J Interferon Res. 1993. PMID: 8301155

8

Absence of biological effects of orally administered interferon-beta ser.

Witt PL, Goldstein D, Storer BE, Grossberg SE, Flashner M, Colby CB, Borden EC. Witt PL, et al. Among authors: borden ec. J Interferon Res. 1992 Dec;12(6):411-3. doi: 10.1089/jir.1992.12.411. J Interferon Res. 1992. PMID: 1289408

9

Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.

Schiller JH, Bushmeyer SM, Ruzicka FJ, Princler GL, Faltynek CR, Borden EC. Schiller JH, et al. Among authors: borden ec. Cancer Res. 1990 Jan 1;50(1):26-31. Cancer Res. 1990. PMID: 2136700

10

Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons.

Greiner JW, Guadagni F, Goldstein D, Borden EC, Ritts RE Jr, Witt P, LoBuglio AF, Saleh MN, Schlom J. Greiner JW, et al. Among authors: borden ec. Cancer Res. 1991 Aug 15;51(16):4155-63. Cancer Res. 1991. PMID: 1907881 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters